Results 1 to 10 of about 2,046,012 (156)

Role of lower extremity fasciectomy plus fasciotomy for patients with persistent leg pain after stenting for chronic iliofemoral venous obstruction [PDF]

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques, 2022
Although clinical improvement after stenting for symptomatic iliofemoral venous obstruction has been demonstrated in multiple large studies, a small proportion of patients will experience persistent quality of life–impairing symptoms.
Arjun Jayaraj, MD   +3 more
doaj   +6 more sources

Intravascular lithotripsy as a treatment option for recalcitrant in-stent restenosis in symptomatic patients with chronic iliofemoral venous obstruction [PDF]

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques
Reinterventions after stenting for chronic iliofemoral venous obstruction have an incidence of approximately 20% to 40% in the literature. The most common reason for this tends to be in-stent restenosis (ISR).
Arjun Jayaraj, MD, FACS
doaj   +6 more sources

Delphi Consensus on Reporting Standards in Clinical Studies for Endovascular Treatment of Acute Iliofemoral Venous Thrombosis and Chronic Iliofemoral Venous Obstruction. [PDF]

open access: yesCirc Cardiovasc Interv, 2023
Acute iliofemoral deep vein thrombosis and chronic iliofemoral venous obstruction cause substantial patient harm and are increasingly managed with endovascular venous interventions, including percutaneous mechanical thrombectomy and stent placement. However, studies of these treatment elements have not been designed and reported with sufficient rigor ...
Vedantham S   +6 more
europepmc   +6 more sources

Indications, technical aspects, and outcomes of stent placement in chronic iliofemoral venous obstruction [PDF]

open access: yesJournal of Vascular Surgery: Venous and Lymphatic Disorders
Iliofemoral venous stent placement (IVS) has evolved to a well-established endovascular treatment modality for chronic iliofemoral venous obstruction (CIVO). Dedicated venous stents gained approval from the US Food and Drug Administration in 2019 and solidified IVS as a defined intervention with clear indications, contraindications, risks, benefits ...
Halbert Bai   +2 more
exaly   +4 more sources

Technique of stent sizing in patients with symptomatic chronic iliofemoral venous obstruction—the case for intravascular ultrasound-determined inflow channel luminal area-based stenting and associated long-term outcomes [PDF]

open access: yesJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2023
Femoroiliocaval stenting has become the standard of care for patients with quality-of-life impairing chronic iliofemoral venous obstruction not responding to conservative measures. Although improvement after stenting has been noted in multiple large studies, sizing of stents has been subjective in nature with a general tendency to use smaller stents ...
Arjun Jayaraj, David Thaggard
exaly   +4 more sources

The beneficial role of complex decongestive therapy in patients with symptomatic chronic iliofemoral venous obstruction with phlebolymphedema [PDF]

open access: yesJournal of Vascular Surgery: Venous and Lymphatic Disorders
Phlebolymphedema has been noted to be one of the most common causes of lymphedema in the lower extremity in western societies. Although complex decongestive therapy (CDT) represents the mainstay of lymphedema treatment, its role for phlebolymphedema arising from chronic iliofemoral venous obstruction (CIVO) merits further exploration. We evaluated this
Arjun Jayaraj
exaly   +4 more sources

Impact of native iliac vein aspect ratio on initial clinical presentation and outcomes following stenting for symptomatic chronic iliofemoral venous obstruction [PDF]

open access: yesJournal of Vascular Surgery: Venous and Lymphatic Disorders
Venous stenting has become the first line of treatment for patients with symptomatic chronic iliofemoral venous obstruction (CIVO) in whom conservative therapy has failed. Intravascular ultrasound (IVUS) interrogation with the use of normal minimal luminal diameters or areas has become the standard to confirm the diagnosis and determine the adequacy of
Arjun Jayaraj
exaly   +4 more sources

Clinical improvement after stenting for chronic iliofemoral venous obstruction: A review of large studies

open access: yesVascular Investigation and Therapy, 2022
A review of large studies where patients underwent stenting for symptomatic chronic iliofemoral venous obstruction (CIVO) and had validated clinical and/or quality of life metrics with a follow-up of at least 12 months was performed.
Arjun Jayaraj, Seshadri Raju
doaj   +2 more sources

Initial experience using VenaCore Catheter for chronic DVT patient [PDF]

open access: yesRadiology Case Reports
Chronic iliofemoral DVT often contains wall-adherent thrombus poorly responsive to lysis. We report lytic-free thrombectomy using VenaCore. A 45-year-old man with acute-on-chronic right iliofemoral DVT (CEAP C4, VCSS 13) underwent popliteal access ...
Victoria Malak, MD   +3 more
doaj   +2 more sources

Positional variation in hemodynamic and morphologic parameters of the iliofemoral venous segment in healthy volunteers [PDF]

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques
Objective: Iliofemoral venous stenting has become the standard of care for patients with quality-of-life-impairing manifestations of chronic iliac venous obstruction.
Arjun Jayaraj, MD, FACS
doaj   +2 more sources

Home - About - Disclaimer - Privacy